Modulation of interleukin-12 synthesis by DNA lacking the CpG motif and present in mycobacterial cell wall complex

Cancer Immunology Immunotherapy

Volumn 49, Issue 6, 2000, Pages 325-334

  Filion, M C ^a   Filion, B ^a   Reader, S ^a   Menard, S ^a   Phillips, N C ^a  

^a Bioniche Therapeutics Research Centre   (Canada)

Author keywords

Cancer; DNA; IL 12; Mycobacterial cell wall

Indexed keywords

BACTERIAL DNA; LIPOSOME; MYCOLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL CELL WALL; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA METHYLATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; MACROPHAGE; MONOCYTE; MOUSE; MYCOBACTERIUM PHLEI; NONHUMAN; PRIORITY JOURNAL;

EID: 0033868848     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620000121     Document Type: Article

References (45)

1. Induction of natural killer activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial D.N.A.
2. DNA and CpG oligonucleotide derived from Babesia bovis are mitogenic for bovine B cells
3. Antitumour and antimetastatic activity of interleukin-12 against murine tumors
4. The mycobacterial cell wall: Structure, biosynthesis and sites of drug action
5. Mycobacterium cell wall: An alternative to intravesical bacillus Calmette Guerin (BCG) therapy in orthotopic murine bladder cancer
6. Lipoteichoic acid preparations of Gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway
7. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure
8. The use of human monocytoid lines as indicators of endotoxin
9. Non-immunologically-mediated cytotoxicity of Lactobacillus casei and its derivative peptidoglycan against tumor cell lines
10. Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells
11. Anti-inflammatory activity of cationic lipids
12. Major limitations in the use of cationic liposomes for DNA delivery
13. Mycobactrium phlei cell wall complex directly induces apoptosis in human bladder cancer cells
14. Peptidoglycan induces transcription and secretion of TNF-α and activation of Lyn, extracellular signal-regulated kinase, and Rsk signal transduction proteins in mouse macrophages
15. In vitro inhibition of murine IFNγ production by phosphorothioate deoxyguanosine oligomers
16. Bacterial DNA induces murine interferon-γ production by stimulation of interleukin-12 and tumor necrosis factor-γ
17. Immunotherapeutic potential in guinea-pig tumor model of deoxyribonucleic acid from Mycobacterium bovis BCG complexed with poly-L-lysine and carboxymethylcellulose
18. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ
19. Contribution of CpG motifs to the immunogenecity of DNA vaccines
20. CpG motifs in bacterial DNA trigger direct B-cell activation
21. Activation of human B cells by phosphorothioate oligodeoxynucleotides
22. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvants
23. The influence of DNA structure on the in vitro stimulation of murine lymphocytes by natural and synthetic polynucleotide antigens
24. Synthetic oligonucleotides: The development of antisense therapeutics
25. Immune stimulation - A class effect of phosphorothioate oligodeoxynucleotides in rodents
26. Mycobacterial cell wall (MCW) as an alternative to BCG in the treatment of carcinoma-in-situ (CIS) of bladder: An efficacy study
27. Immunotherapy of an experimental adenocarcinoma of the prostate
28. Recombinant interleukin-12 (IL-12) administration induces tumor regression in association with interferon-γ production
29. Postoperative adjuvant immunotherapy of gastric cancer with BCG-cell wall skeleton. 3- to 6-year follow up of a randomized clinical trial
30. Environmental mycobacteria in bottled table waters in Greece
31. Local expression of cytokines in rat bladder carcinoma tissue after intravesical treatment with Nocardia rubra cell wall skeleton and bacille-Calmette-Guerin
32. Immunostimulatory DNA sequences function as T-helper-l-promoting adjuvants
33. Secretion of interleukin-6 (IL-6) by human monocytes stimulated by muramyl dipeptide and tumour necrosis factor alpha
34. Immunotherapy of Lewis lung carcinoma with hydrosoluble peptidoglycan momoner (PGM)
35. Macrophages sense pathogens via DNA motifs: Induction of tumor necrosis factor-α-mediated shock
36. Interleukin-12 an integral cytokine in the immune response
37. Macrophage dependency of T-lymphocyte mitogenesis by Nocardia rubra-cell wall skeleton
38. Mitogenicity of DNA from different organisms for murine B cells
39. Antitumor activity of deoxyribonucleic acid fraction from Mycobacteriurn boris B.C.G. I. Isolation, physicochemical characterization and antitumor activity
40. Roles of the bacterial cell wall and capsule in induction of tumor necrosis factor alpha by type III group B streptococci
41. Inhibition of angiogenesis in vivo by interleukin 12
42. Base composition of deoxyribonucleic acid isolated from mycobacteria
43. Immunotherapy of cancer with cell wall skeleton of Mycobacterium boris-Bacillus Calmette-Guerin: Experimental and clinical results
44. Nonspecific adjuvant immunotherapy of lung cancer with cell wall Skeleton of Mycobacterium bovis Bacillus Calmette-Guerin
45. Dissecting the antigenic active components of BCG: Role of BCG cell wall inner membrane and cytoplasm